RE:RE:RE:RE:RE:Jumps ship? Or perhaps was let go...Allan Oberman has to ask himself just one question....would you rather go into this...
The CMA is investigating suspected unfair pricing in the supply of certain pharmaceutical products under Chapter II CA98/Article 102 TFEU
October 2016 Investigation opened
October 2016 to February 2017 Initial investigation, information gathering, including issuance of formal or information requests and parties’ responses. CMA analysis and review of parties’ responses to information requests. Potential state of play meetings with parties under investigation
February 2017 Decision whether or not to proceed with the investigation or to close the investigation
With this.....
https://www.thetimes.co.uk/article/lessons-in-exploiting-a-loophole-to-make-millions-out-of-the-nhs-mtp7kl2x0
Or this.....
Graeme Duncan
Managing Director, Concordia International
Graeme joined in 2015 as Global Marketing Director and UK Commercial Director. His responsibilities include marketing and promotion activities throughout the group. Graeme brings a wealth of experience with him having worked for almost 20 years within the areas of strategy, marketing, commercial excellence and general management.
Much of this experience has been within the life sciences sector. Notably Graeme has held senior management roles in GlaxoWellcome, GSK and IVAX within the pharmaceutical sector. Most recently Graeme was on the board of Healthcare at Home, the largest home healthcare company in Europe, where he was the Group Director of Strategy and Marketing. Having commenced his career within the UK, Graeme's experience includes international expansion and growth.
Having little connection to Cinven....